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Phosphorylation of the negative-sense RNA virus phosphoproteins is highly conserved, implying functional significance.
Sendai virus (SV) phosphoprotein (P) is constitutively phosphorylated at S249. Abrogation of the SV P primary phosphory-
lation causes phosphorylation of P at alternate sites, creating a problem in determining the function of phosphorylation. We
have now identified the alternate phosphorylation sites using two-dimensional phosphopeptide analysis of several deletion
and point mutants of the P protein. The alternate phosphorylation sites were mutagenized to create P with (S249combo) or
without (combo) primary phosphorylation. The combo protein has less than 10% phosphorylation compared with the wild-type
P or S249combo. Functional analysis of the mutant proteins using a Sendai virus minigenome replication system showed that
the combo P protein was as proficient in supporting minigenome replication as the wild-type P in cell cultures. These studies
suggest that like the primary, the alternate phosphorylation of the P protein is also dispensable for virus replication in cell
cultures. Interestingly, the ability of the multiple site mutant of P (combo mutant has eight serine residues changed to alanine
residues) to support efficient virus RNA synthesis suggests that the P protein has a high flexibility at least in its sequence
and perhaps also in structure. © 2000 Academic PressINTRODUCTION
Sendai virus (SV), a prototypic member of the family
Paramyxoviridae, is an enveloped RNA virus with a sin-
gle-stranded, negative-sense genome of about 15 kb
(Lamb and Kolakofsky, 1996; Nagai, 1999). The genome
encodes six viral genes: NP, P/V/C, M, F, HN, and L.
Three viral proteins NP, P, and L are necessary and
sufficient for viral RNA synthesis (Horikami et al., 1992).
NP encapsidates the genome into a ribonucleoprotein
complex (RNP), which serves as a template for viral RNA
synthesis. The viral RNA polymerase, a complex of P and
L, is responsible for viral transcription and genome rep-
lication. Although the L protein is believed to have all
catalytic activities for RNA synthesis, P is essential for
the polymerase activity (Smallwood et al., 1999). More-
over, P is required for the L protein stability (Horikami et
al., 1992) and for the binding of NP to form RNP template
(Curran et al., 1995).
Constitutive phosphorylation of phosphoproteins in
negative-sense RNA viruses is conserved, implying a
functional significance of P phosphorylation. Several
studies on P phosphorylation in some negative-sense
RNA viruses indicated that the P protein phosphorylation
is indispensable for viral transcription, although not for
replication. For vesicular stomatitis virus (VSV) Indiana P,
1 Portions of this work will be submitted in partial fulfillment for the
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517the major phosphorylation sites are S60, T62, and S64
(Chen et al., 1997; Jackson et al., 1995). The P of VSV New
Jersey is phosphorylated at S59 and S61 (Das et al., 1995;
Takacs et al., 1992). In Chandipura virus, P phosphory-
lation occurs at S62 (Chattopadhyay et al., 1997). The
respiratory syncytial virus (RSV) P was shown to be
phosphorylated at S232 and S237 (Barik et al., 1995;
Mazumder et al., 1994; Mazumder and Barik, 1994;
Sanchez-Seco et al., 1995). All of these studies sug-
gested that the P phosphorylation is directed by cellular
casein kinase II and is required for transcription but not
for RNA replication (Barik and Banerjee, 1992a,b; Beckes
and Perrault, 1992; Das et al., 1995; Pattnaik et al., 1997).
In contrast, hPIV3 P phosphorylation at S333 was shown
to be mediated by the cellular protein kinase C isoform z
(De et al., 1995; Huntley et al., 1995). Recent studies with
the VSV P suggested that phosphorylation is required for
the appropriate folding of the P protein and self-oli-
gomerization (Gao and Lenard, 1995a, 1995b). A major
limitation with most of these studies has been the use of
Escherichia coli expressed P, its in vitro phosphorylation,
and cell-free RNA synthesis. These conditions may not
reflect the intracellular status of P in infected cells as
was recently demonstrated for the SV P (Byrappa et al.,
1995, 1996).
Like other negative-sense RNA virus phosphoproteins,
SV P is constitutively phosphorylated (Hendricks et al.,
1993; Hsu and Kingsbury, 1982). We recently showed that
the SV P is primarily phosphorylated at S249 in SV-
infected and P gene-transfected cells (Byrappa et al.,
1996). This conclusion was reconfirmed by using mass
0042-6822/00 $35.00
Copyright © 2000 by Academic Press
All rights of reproduction in any form reserved.
S
w
(
D
D
518 HU AND GUPTAspectrometric analysis of the purified P protein from
insect cells that we supplied (Jonscher and Yates, 1997).
Because the mutation of P250 to alanine abrogated S249
phosphorylation (Byrappa et al., 1996), the enzyme for
phosphorylation appears to be a proline-directed protein
kinase. Although phosphorylation at S249 accounts for
about 80% of phosphate content of P, mutagenesis of
S249 to alanine did not reduce the level of P phosphor-
ylation due to increased phosphorylation at alternate
sites (Byrappa et al., 1996). The increased alternate
phosphorylation after abrogation of the primary phos-
phorylation indicated that the constitutive phosphoryla-
tion of P at S249 was important for maintaining the
structural integrity of the phosphoprotein.
Recently, we examined the role of primary phosphor-
ylation of SV P in RNA transcription, replication, and
self-oligomerization in a minigenome replication system.
Our results showed that the primary phosphorylation of P
protein is dispensable for virus RNA synthesis and self-
oligomerization in cell cultures (Hu et al., 1999). Impor-
tantly, we generated Sendai virus mutants that were
deficient in the primary phosphorylation. Growth of mu-
tant viruses both in cell culture and in its natural host
(mice) was not significantly different from that of the
wild-type (WT) (parent) virus. The pathogenesis of the
mutant viruses was also similar to that of the parent
virus. We therefore concluded that the primary phosphor-
ylation of P did not have an essential function in SV
replication and pathogenesis (Hu et al., 1999). However,
determination of P phosphorylation function was compli-
cated by phosphorylation at alternate sites of P (Byrappa
et al., 1996). It is possible that the alternate phosphory-
lation of P compensates for the lack of primary phos-
phorylation. To examine this possibility, we identified
alternate phosphorylation sites of SV P and created P
mutants that lack the primary and/or alternate phos-
phorylations. WT P was substituted with one of these
mutants in a minigenome replication system to deter-
mine the role of phosphorylation in virus replication.
RESULTS
To define the role of alternate phosphorylation in SV P,
it was necessary for us to determine the alternate phos-
phorylation sites. Our previous phospho-amino acid
analyses of SV P and its deletion mutants (with alternate
phosphorylation) showed that P and its mutants were
phosphorylated only at serine residues (Byrappa et al.,
1996). SV P is a relatively serine-rich protein; serine
accounts for 12.3% of the total amino acids (aa) in P. On
complete digestion of SV P, trypsin is expected to gen-
erate 77 peptides, among them are 34 serine-containing
peptides. Phosphopeptide analysis of S249A mutant of P
revealed at least 10 additional peptides phosphorylated
to varying degrees (Byrappa et al., 1996). To identify the
phosphoserine residues in these peptides, we first local-ized the alternate phosphopeptides in P (described
later). Two sets of mutants spanning the entire P protein
(aa 1–568) were created. Deletion and point mutations in
the middle (aa 145–434) region in the first set and dele-
tion mutations in the amino (aa 1–144) and carboxyl (aa
435–568) -terminal regions of P in the second set were
created. Deletion mutants were designed to delete one
or more tryptic peptides. Thus, one or more phosphopep-
tides would be missing in the two-dimensional phos-
phopeptide map if the mutant lacks a phosphorylation
site. However, the mobility of peptides is expected to
remain unchanged if no additional modification occurred
in the phosphopeptide (Byrappa et al., 1996). To facilitate
the location of the alternate phosphorylation sites, all
mutants were created in vector pTF1SVPS249A, which
carries S249A mutation that abolishes the primary phos-
phopeptide, TP1. This mutation allows facilitated detec-
tion of the alternate phosphorylation sites due to the
increased phosphorylation at these sites (Byrappa et al.,
1996).
Analysis of the middle region deletion mutants
The full-length P protein is 568 aa long. However,
initially, the middle region of P protein (aa 145–434) was
targeted for mutagenesis because this region was ex-
pected to contain two alternate phosphorylation sites:
TP2 and TP3 (Byrappa et al., 1996). Moreover, we were
not aware of an antibody that would immunoprecipitate
deletion mutants downstream of 434 aa as our anti-P
peptide antiserum was primarily directed to aa 453–477
(Byrappa et al., 1995).
Deletion mutants spanned aa 179–434 (Fig. 1A). A
point mutation S149A was created to span aa 145–178,
because S149 is the only serine within this region. SDS-
PAGE analysis of immunoprecipitated proteins showed
that all mutants were expressed (Fig. 1B, 35S panel) and
phosphorylated to varying degrees (Fig. 1B, 32P panel).
However, none of middle region mutants abrogated P
phosphorylation, indicating that the P protein is phos-
phorylated at multiple sites. To locate any missing phos-
phopeptide(s) from the mutant proteins, two-dimensional
(2-D) phosphopeptide mapping was performed for each
of the mutant P protein.
Our designations for phosphopeptides are based on a
previous report (Byrappa et al., 1996). The map of mutant
149A (Fig. 2C) is identical to the parent S249A (Fig. 2B),
hich has three major (TP2, TP3, and TP4) and six minor
TPt1, TP5, TP6, TP7, TP9, and TP11) phosphopeptides.
eletion mutants D197-207 (Fig. 2E), D294-316 (Fig. 2G),
317-357 (Fig. 2H), D361-409 (Fig. 2I), and D410-434 (Fig.
2J) also gave phosphopeptide maps similar to that of
S249A. However, in mutant D179-196 (Fig. 2D) TP7 and in
mutant D208-282 (Fig. 2F), TP3 was missing. This obser-
vation is consistent to our previous report that TP3 is
located between aa 254–316 (Byrappa et al., 1996).
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single tryptic peptide spanning aa 255–282, which con-
tains serine residue at 257, 260, 267, and 275. Interest-
ingly, deletions of aa 317-357 (Fig. 2H) and aa 361-409
(Fig. 2I) reduced phosphorylation levels at TP2 and TP4
indicating their reduced exposure to kinase or increased
exposure to phosphatase. This could result from a con-
formational change in the mutant P proteins (Byrappa et
al., 1996). These results showed that not all alternately
phosphorylated peptides were located in the middle re-
FIG. 1. Schematic presentation (A) and expression (B) of the SV P
owever, only the region spanning aa 145–434 of SV P is shown. Deleti
sing Vent polymerase (see Materials and Methods). Broken line repre
ight side. Amino acids 145–178 contain only one serine (S149), so a
hosphorylation (right) of deletion mutants in CV-1 cells using vTF7-3 sy
eletion mutant D208-282 was constructed later and is not included
olyclonal rabbit antiserum against P was used for immunoprecipitatigion but rather are distributed through the entire P pro-
tein.Because we did not have an antibody that would
specifically bind the carboxyl-terminal region (aa 435–
568) of the P protein, we determined the binding site of
an anti-P monoclonal antibody M56 that has an unknown
determinant toward the carboxyl-terminal half of the P
protein (Deshpande and Portner, 1985). M56 was unable
to immunoprecipitate deletion mutants D317-357 and
D361-409, localizing the binding epitope for M56 be-
tween aa 317 and 409. The location of M56 epitope to the
middle region provided us with a reagent for immuno-
region deletion mutants. (A) The full-length P protein is 568 aa long.
point mutants were generated by PCR amplification of pTF1SVPS249A
e deleted region with the precise amino acid deletion indicated at the
utant S149A was used to cover this region. (B) Expression (left) and
5S-Labeled (left) and 32P-labeled (right) immunoprecipitated P proteins.
el B. WT and S249A lanes are from a separate gel. The anti-peptide
e mutant proteins.middle
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520 HU AND GUPTAAnalysis of amino and carboxyl deletion mutants
The amino-terminal 144 amino acid region of P protein
has eight serine-containing tryptic peptides. Five over-
lapping deletion mutants were constructed that spanned
the entire 144-aa region, with each mutant deleting four
peptides (Fig. 3A). Phosphopeptide analysis of these
mutants should localize the phosphopeptide to a single
peptide level without having to make eight single peptide
deletion mutants. The carboxyl-terminal of P (aa 435–
568) has 10 serine-containing tryptic peptides (Fig. 3B).
Six overlapping deletion mutants were constructed with
the strategy similar to that used for constructing the
amino-terminal mutants, except that each mutant deleted
five peptides. Protein expression (35S-labeled protein) of
ach deletion mutant is shown in Fig. 3C. Due to the lack
f binding domain of the anti-peptide antiserum in the
FIG. 2. Two-dimensional tryptic phosphopeptide maps of the midd
D197-207, (F) D208-282, (G) D294-316, (H) D317-357, (I) D361-409, and
Methods. Phosphopeptide designations are identical to those describe
that the alternate phosphopeptides are readily detected in S249A (B) c
from the P gene plasmid carrying S249A mutation (pTF1SVPS249A) as53–477 aa region, deletion mutants D435-509, D447-
14, D454-523, and D456-533 were immunoprecipitatedy the monoclonal antibody M56. As described, the bind-
ng region of M56 is located in the 317–409 aa region. All
f the amino-terminal deletion mutants (D10-83 through
84-144) and carboxyl-terminal deletion mutants D476-
45 and D510-568 were immunoprecipitated using the
nti-peptide polyclonal antiserum (Byrappa et al., 1995).
nonspecific band with a size similar to the WT P was
bserved whenever M56 was used (asterisk). However,
his band created no problem in our phosphorylation
nalysis because it was not phosphorylated (Fig. 3C). In
he deletion mutant D435-509, there are two phosphory-
lated proteins. The lower band was used for phos-
phopeptide analysis, as it was the expected size mutant
protein. The nature of upper band (open circle) is un-
known, but it is not a WT contaminant as determined by
the phosphopeptide mapping of the upper band (data not
on deletion mutants: (A) WT, (B) S249A (C) S149A, (D) D179-196, (E)
-434. Phosphopeptides were analyzed as described in Materials and
rappa et al. (1996). Note that TP1 is eliminated by S249A mutation and
d with WT (A). All P gene deletion and the S149A mutants are derived
ibed in Materials and Methods.le regi
(J) D410
d by By
ompare
descrshown).
Phosphopeptide analysis of the amino-terminal mu-
n521ROLE OF SENDAI VIRUS PHOSPHOPROTEINtants located TP6 to tryptic peptide aa 66–83 as TP6 was
missing from deletion mutants D10-83 (Fig. 4A), D17-89
(Fig. 4B), D48-93 (Fig. 4C), and D66-108 (Fig. 4D) but was
present in D84-144 (Fig. 4E). TPt1 was located at 108-144,
because it was abolished with the deletion of D84-144
(Fig. 4E) and was present in the mutants D10-83 and
D66-108. The intensity of labeling of TPt1 and TP9 in
amino-terminal deletion mutants was higher than ob-
FIG. 3. Schematic presentation (A and B) and expression (C) of t
region mutants from aa 1–144 are shown. (B) Carboxyl-terminal reg
deleted peptide of the P protein with deleted aa region shown at
peptides (numbered 1–8 and 1–10). There are 8 serine-containing p
435–568. Each deletion mutant in amino-terminal region spans four
SDS–PAGE analysis of immunoprecipitated amino- and carboxyl-ter
Deletion mutants D435-509, D447-514, D454-523, and D456-533 w
located within aa 317–409. Other deletion mutants were immunoprec
used for phosphopeptide analysis are marked by solid dots (Fi
nonspecifically immunoprecipitated protein with monoclonal antibo
onspecific band in D435-509 (see 35S panel) that is also phosphory
to D435-509 was used for phosphopeptide analysis.served in S249A and in the middle region mutants (see
Fig. 2). It is probably due to a better access of thephosphorylation sites in TPt1 and TP9 for kinases or to a
reduced access to phosphatases caused by a conforma-
tional change in the amino-terminal deletion mutants
(Byrappa et al., 1996).
Phosphopeptide maps of the six carboxyl-terminal de-
letion mutants localized TP2 within aa 447–453, as TP2
was missing from deletion of D435-509 (Fig. 4F) and
D447-514 (Fig. 4G) but was present in D454-523. How-
P amino and carboxyl region deletion mutants. (A) Amino-terminal
tants from aa 435–568 are shown. The broken lines represent the
ht. Vertical bars in the top lines indicate serine-containing tryptic
in the amino-terminal aa 1–144 and 10 in the carboxyl-terminal aa
es, and that in the carboxyl-terminal region spans five peptides. (C)
deletion mutants. 35S-Labeled (left) and 32P-labeled (right) proteins.
munoprecipitated by monoclonal antibody M56, whose epitope is
by the anti-peptide antiserum (described in Fig. 1). Mutant proteins
32P panel). The asterisk (35S panel, lane D454-523) denotes a
but is not phosphorylated (see 32P panel). Open circle indicates a
see 32P panel). Only the lower phosphorylated band correspondinghe SV
ion mu
the rig
eptides
peptid
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g. 3C,
dy M56
lated (ever, the phosphorylation level of TP2 in the deletion
mutants D454-523, D456-533, and D476-545 was rather
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522 HU AND GUPTAweak, indicating that deletions affected the conformation
of mutants, causing their increased dephosphorylation
or reduced phosphorylation. Deletion of aa 456–568 ap-
parently affected the conformation of P protein such that
there is an extra phosphopeptide (designated as X1) in
the deletion mutants D456-533 (Fig. 4I) and D476-545
Fig. 4J). In deletion mutant D510-568 (Fig. 4K), in addition
o X1, another peptide X2 was heavily phosphorylated.
Analysis of middle, amino-, and carboxyl-terminal de-
etion mutants located the two major alternate phos-
hopeptides (TP2 and TP3) and three minor phos-
hopeptides (TP6, TP7, and TPt1). Although the deletion
nd point mutants covered every serine, threonine, and
yrosine residues in the P protein, we failed to localize
lternate phosphopeptides TP4, TP5, TP9, and TP11. It is
ossible that SV P was always contaminated with a
hosphorylated cellular protein that yielded TP4, TP5,
P9, and TP11. Another possibility, albeit low, is that
hese peptides are indeed from P protein but could not
FIG. 4. Two-dimensional tryptic phosphopeptide maps of amino- an
D66-108, (E) D84-144, (F) D435-509, (G) D447-514, (H) D454-523, (I) D45
in deletion mutants of D456-533, D476-545, and D510-568. X2 denotese resolved as two or more peptides migrated at the
ame position in the 2-D map.Analysis of point mutants to determine
phosphorylation sites
To localize the phosphoserine residues in phos-
phopeptides, individual serine residue was indepen-
dently mutated to alanine. As shown in Fig. 5, TP6, TPt1,
and TP7 each has three serine residues, whereas TP3
has four and TP2 has two serine residues. Mutagenesis
of S68 (Fig. 6A), S125 (Fig. 6B), and S192 (Fig. 6C) to
alanine abolished phosphopeptides TP6, TPt1, and TP7,
respectively, showing that S68, S125, and S192 were
phosphorylated. However, no single serine-to-alanine
mutation in TP2 and TP3 abolished the phosphopeptides
(data not shown), implying that more than one phospho-
serines was present in these peptides. As predicted,
double-point mutant S447A/S449A eliminated TP2 (Fig.
6E). TP3 contained four serine residues: S257, S260,
S267, and S275. Based on the results from TP1 and TP2,
we predicted that the alternate phosphorylation site in
oxyl-terminal deletion mutants: (A) D10-83, (B) D17-89, (C) D48-93, (D)
J) D476-545, and (K) D510-568. X1 represents an extra phosphopeptide
r extra phosphopeptide in D510-568.d carbTP3 is an -SP- site. The only -SP- site in TP3 is at S260.
To test our prediction, a double-mutant, S257A/S260A,
sosphat
523ROLE OF SENDAI VIRUS PHOSPHOPROTEINand a triple-mutant, S257A/S260A/S275A (to test whether
S267 was phosphorylated), were made. The double-mu-
tant (S257A/S260A) abolished TP3 (Fig. 6D), showing that
TP3 was phosphorylated at S257 and S260 and not at
S267 and S275.
To construct a P mutant that lacked the majority of
phosphorylation, phosphoserine residues (marked with
asterisks in Fig. 5) were mutated to alanine residues in
one construct. This combo mutant was constructed
through intermediate mutants. A phosphopeptide map of
each mutant was generated to unambiguously deter-
mine the abrogation of one or more phosphorylation
sites. Mutant S68A/S125A (Fig. 6F, lacked TP6 and TPt1)
was generated by mutagenesis of S125 to alanine using
mutant plasmid S68A as a PCR template. Mutant S192A/
S257A/S260A was generated by the introduction of
S192A mutation in S257A/S260A. Mutant S192A/S257A/
S260A/S447A/S449A (Fig. 6G, lacked TP7, TP3, and TP2)
was a result of ligation of 4012-bp PstI–EagI fragment
from S192A/S257A/S260A with a 965-bp PstI–EagI frag-
ment from S447A/S449A. The combo plasmid (Fig. 6H)
was constructed by replacing the 1300-bp EcoNI–BamHI
fragment of S68A/S125A with the same fragment from
S192A/S257A/S260A/S447A/S449A. In the combo mu-
tant, poorly phosphorylated TP4, TP9, and TP11 were still
detected (Fig. 6I). However, the origin of these peptides
FIG. 5. Schematic representation of the P protein with its functional d
Relative location of each phosphopeptide in P protein is shown. Positio
phosphopeptide was mutated to alanine. An asterisk represents the ph
with phosphorylated -SP- sites are boxed.is not clear (described earlier). In addition to the combo,
mutant 249combo (Fig. 6I) was also constructed in which
l
cthe primary phosphorylation site was retained, yet the
alternate sites (described earlier) were abrogated. Re-
markably, abrogation of the majority of phosphoserines
did not create any more detectable alternate phosphor-
ylation site, indicating that no additional phospho-ac-
cepting sites exists in the P protein. This fact also en-
abled us to create P with less than 10% phosphorylation
compared with the WT P.
Phosphorylation of the combo mutant
To examine phosphorylation status of combo and
S249combo proteins in CV-1 cells, proteins were labeled
metabolically with Trans35S-label for the level of expres-
ion or [32P]orthophosphate for the level of phosphoryla-
tion. Labeled proteins were immunoprecipitated with an-
ti-peptide antiserum (described in Materials and Meth-
ods). Immunoprecipitations were carried out in duplicate
from two independent transfections, each with an inde-
pendently isolated P mutant clone. Expression levels of
the combo proteins were similar to the WT and S249A
proteins (Fig. 7A, 35S panel). However, phosphorylation
level of combo is less than 10%, and that of S249combo
is about 60% compared with the WT P protein (Fig. 7B).
The faint phosphorylated band at P protein position in
combo transfections (Fig. 7A, 32P panel) is due to very
identified by previous investigators (adopted from Curran et al., 1994).
ery serine residue in the phosphopeptide is given. Each serine in the
e acceptor serine in the individual phosphopeptides. Phosphopeptidesomains
n of evow level phosphorylation of the combo and a nonspe-
ific band observed in nontransfected or vTF7-3-infected
bo refe
524 HU AND GUPTACV-1 cells (data not shown). These results showed that
the combo mutants are stably expressed in CV-1 cells,
indicating that phosphorylation is not important for P
protein stability. Moreover, we were able to create a
mutant of the P protein that has very little phosphoryla-
tion (,10% relative to WT P) that can be used to study the
role of P phosphorylation.
Role of P protein phosphorylation
FIG. 6. Two-dimensional tryptic phosphopeptide maps of single- or
S447A/S449A, (F) S68A/S125A, (G) S192A/S257A/S260A/S447A/S449A,
phosphorylation at TP1, TP2, TP3, TP6, TP7, and TPt1, whereas S249com
at TP1.An SV minigenome replication system using T7 RNA
polymerase from recombinant vaccinia virus (vTF7-3)was established and used successfully in defining the
function of SV P primary phosphorylation (Hu et al., 1999).
This system was described in detail in a previous report
(Hu et al., 1999). Briefly, the luc gene in the minigenome
pSNDluc is in the antisense orientation relative to the
T7-directed RNA transcription and is flanked by the
trailer and the leader noncoding regions of SV. Conse-
quently, the T7 transcript of the minigenome plasmid
contains a negative-sense luciferase RNA flanked with
e-point mutants: (A) S68A, (B) S125A, (C) S192A, (D) S257A/S260A, (E)
combo, and (H) combo. Combo represents the P mutant that lacks the
rs to the mutant that lacks the phosphorylation at all these sites exceptmultipl
(I) S249the leader and the trailer sequences of SV. Thus lucif-
erase activity will be detected only if the encapsidated
pation w
M
525ROLE OF SENDAI VIRUS PHOSPHOPROTEINminigenome is replicated and transcribed by the viral
RNA polymerase.
A detailed procedure to monitor the minigenome rep-
lication in CV-1 cells has been described previously (Hu
et al., 1999). Transfection amounts of NP, P, and L recom-
binant plasmids were critical for the success of mini-
genome replication. Because the combo mutants were
generated in pTF1 vector (in contrast to pCDNA used in
Hu et al., 1999), we reoptimized the amount of WT SV P
FIG. 7. SDS–PAGE analysis of WT and combo mutants. (A) Left panel p
resents the immunoprecipitation of 32P-labeled P proteins. Transfection
isolated clones. (B) Level of phosphorylation of P mutants is presented
quantified by a PhosphorImager (Molecular Dynamics). 32P incorpor
aterials and Methods).plasmid (pTF1SVP) for transfection. Eighty nanograms of
WT P plasmid was found to be optimum for minigenomereplication as determined by the luciferase activity. Forty
nanograms of pTF1SVP generated about half of the lu-
ciferase activity generated with 80 ng. However, doubling
of plasmid amount to 160 ng did not increase luciferase
activity.
To determine whether the abrogation of total (combo)
or alternate phosphorylation alone (S249combo) plays a
role in the minigenome replication, an indicated amount
of the P plasmid or its mutant plasmid was cotransfected
s the immunoprecipitation of 35S-labeled P proteins, and the right panel
mmunoprecipitations were performed in duplicates from independently
cent with respect to the WT (100%). Radioactivity in protein bands was
as normalized with 35S incorporation in a parallel experiment (seeresent
s and i
as perwith minigenome, L and NP plasmids. After transfection,
cell lysates were prepared and assayed for the lucif-
n
c
a
n
p
t
a
p
d
p
W
c
e
b
W
i
Laemmli gel (Laemmi, 1970). (C) Northern blot analysis of the mini-
genome RNA from encapsidated molecules. C lane is for the mock-
526 HU AND GUPTAerase activity. The results (average of five independent
experiments) showed that the mutants were capable of
supporting the minigenome transcription and replication
(Fig. 8A) with slightly greater efficiency than the WT.
However, the paired t test analysis of the data revealed
o significant difference between the WT P and the
ombo P RNA synthesis levels. Luciferase activity for
lternate phosphorylation alone (S249combo) also was
ot significantly different from that of the WT P. Immuno-
recipitation of P protein in parallel experiments showed
hat WT and mutant P proteins were expressed in similar
mounts in transfected cells (Fig. 8B). As expected, ex-
ression of P protein from 80 ng of P plasmid was about
ouble compared with the protein level from 40 ng of the
lasmid. Contamination of combo mutant plasmid with
T P plasmid was ruled out by complete digestion of the
ombo plasmid with ApaI (data not shown). Fortuitously,
the S447A mutation (Fig. 5) in the combo mutant created
a new ApaI site.
Encapsidated minigenome replication products were
analyzed after micrococcal nuclease digestion in a
Northern blot using a negative-sense luciferase RNA
probe (Hu et al., 1999). As expected, both combo mutant
and S249combo were found to be as active as the WT P
protein in supporting minigenome replication (Fig. 8C).
Here also, the level of replication product (1932 nt) was
proportional to the amount of transfected P plasmid. The
level of replication with combo and S249combo was
relatively higher than with the WT P. Replication with
combo was about twofold more than that with the WT
(see Discussion).
Although the levels of luciferase activity and replica-
tion products corresponded well (compare Figs. 8A and
8C), it may be noted that luciferase activity measures
both transcription and replication of the minigenome. To
directly determine the transcription activity with each P
mutant, we constructed a bicistronic minigenome, pSND-
biluc. In this construct, SV gene junction region (EIS 5 24
nt) (Gupta and Kingsbury, 1984) was inserted at nt 590
from the start codon of the luciferase gene in the mini-
genome. Transcription of this bicistronic minigenome by
SV RNA polymerase was expected to generate RNA
species of 1000 and 600 nt. Northern blot analysis of the
total RNA from transfected cells using negative-sense
luciferase RNA as probe showed that both expected size
RNA species were generated in WT and mutant P plas-
mid transfections from the bicistronic minigenome (Fig.
9). The levels of transcripts synthesized with WT, S249A,
S249combo, and combo are very similar. However, the
levels of RNA with S249combo and combo are slightly
higher than that of the WT. These results correspond well
transfected cells, and M lane is for the size marker RNA. Size of theFIG. 8. Sendai virus minigenome replication with phosphorylation-
deficient P mutants in transfected cells. vTF7-3-infected CV-1 cells
were transfected with pSNDluc, NP, L plasmids, and 40 or 80 ng WT P
or mutant P (S249A, S249combo, or combo) as indicated. (A) Luciferase
activity supported by phosphorylation-deficient P mutants was mea-
sured as relative light units/mg protein. Results from five independent
xperiments were averaged with the deviations shown by the error
ars. (B) Expression of P protein in transfected cells from mutants and
T constructs in a parallel experiment. 35S-labeled proteins were
mmunoprecipitated with anti-peptide serum and analyzed in a
marker RNA (1600 nt) is indicated by an arrow. The predicted size of
minigenome RNA is 1932 nt.
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527ROLE OF SENDAI VIRUS PHOSPHOPROTEINwith the slightly increased luciferase activity as mea-
sured for transcription and replication of the minigenome
replication (see Fig. 8A). Furthermore, these results show
that P phosphorylation is not involved in recognition of
gene junction signals as the expected RNA species were
appropriately synthesized. The direct examination of
transcription products showed that the absence of pri-
mary and/or alternate phosphorylations in P protein did
not affect the transcription of SV polymerase.
The results presented above clearly show that the
primary and/or alternate phosphorylations of the P pro-
tein are dispensable for SV minigenome transcription
and replication in vTF7-3-infected CV-1 cells.
DISCUSSION
Despite several attempts at defining the role of phos-
phorylation in the phosphoproteins of negative-sense
RNA viruses, the function remains enigmatic. Our initial
attempt at determination of the role of SV P phosphory-
lation was hampered by phosphorylation at alternate
sites after the primary phosphorylation was abrogated
(Hu et al., 1999). Now, we have determined the major
lternate phosphorylation sites in the P protein and ab-
ogated their phosphorylation by mutagenizing the phos-
ho-accepting serine residues to alanine residues. Al-
hough our mutants spanned the entire P protein, we
ailed to locate all the alternate phosphorylation sites.
he unspecified serine residues are in phosphopeptides
P4, TP5, TP9, and TP11, which are poorly phosphory-
ated. In no case did aggregate phosphorylation at these
ites account for more than 10% of the total phosphory-
ation (see Figs. 2, 4, 6, and 7). A possibility exists that
hese phosphopeptides are from a cellular protein that
omigrates with the P protein. Nevertheless, we have
ucceeded in locating the major alternate phosphoryla-
FIG. 9. . Northern blot analysis of transcripts from the bicistronic
minigenome. Total cellular RNA from transfected cells was used and
probed with the negative-sense luciferase probe. The amount (40 or 80
ng) of transfected P constructs is shown on the top of each lane. The
expected size products 1000 and 600 nt are shown by arrows. The
position of the size marker (1600 nt) in lane is also shown by an arrow.
Lane C presents RNA from the mock-transfected cells.ion sites that together account for more than 90% of
lternate phosphorylation. This is confirmed by less than
c
t0% phosphorylation of the combo mutant compared
ith the WT P or mutant S249A. Taken together, the
esults show that the prominent alternate phosphoryla-
ion sites have been identified.
Each of the major alternate phosphopeptides TP2 and
P3 has two phosphoserines, of which one occurs in an
SP- motif. It is interesting to recall that SV P was primar-
ly and constitutively phosphorylated at S249 at an -SP-
otif (Byrappa et al., 1996). Similarly, the major phos-
horylation site of human parainfluenza virus type 1
HPIV1), a virus closely related to SV, was also located at
n -SP- site (S120P121) (Byrappa and Gupta, 1999). The
SP- locus is the minimal target site for proline-directed
rotein kinases (PDPKs). PDPKs include kinases that are
mportant for intracellular signaling such as mitogen-
ctivated protein kinase, cyclin-dependent protein ki-
ase 5, and glycogen synthase kinase 3 (Cano and
ahadevan, 1995; Pelech, 1995). The conservation of
ajor phosphorylation at -SP- motifs and its functional
ignificance are not clear but indicate a common theme
n phosphorylation.
Although PDPK plays a major role in SV P phosphor-
lation, other cellular kinases also participate in the
lternate phosphorylation of SV P. S68 and S267 appear
o be the targets for casein kinase II-mediated phosphor-
lation. Sequences at other alternate sites do not match
ny consensus phosphorylation target site for the known
inases. Serine residues at the alternate phosphoryla-
ion sites of SV P at 257, 447, and 449 are also conserved
n HPIV1 P. However, it is not determined whether these
erine residues are alternately phosphorylated in HPIV1
. Surprisingly, none of the identified phosphorylation
ites are potential targets for protein kinase C, which
as reported to be involved in the cell-free phosphory-
ation of SV P (Huntley et al., 1997). These observations
gain underscore the importance of examining the phos-
hoproteins in vivo.
The function of the primary phosphorylation at S120 of
PIV1 has not been determined. However, the primary
hosphorylation of SV P at S249 was found to be dis-
ensable for viral RNA synthesis in both cell culture and
ouse (Hu et al., 1999). Because SV P and HPIV1 P have
he potential for phosphorylation at alternate sites, it is
ossible that a general phosphorylation rather than
hosphorylation at specific residues is important. To test
his idea, we located the majority of the alternate phos-
horylation sites of SV P (Fig. 5) and created a P mutant
combo) that has less than 10% phosphorylation level
ompared with the WT P (Fig. 7). Abrogation of the
lternate phosphorylation (-SP- and other minor) sites
id not inactivate the P protein in supporting minigenome
ranscription and replication. The luciferase activity mea-
urements and the Northern blot analysis for the prod-
cts of minigenome transcription as well as replication
learly showed that combo P protein was as effective as
he WT P (Figs. 8 and 9).
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528 HU AND GUPTAVarious structural and functional domains of SV P have
been defined (Fig. 5). Using cell-free protein-protein as-
sociation assays, the nucleocapsid-binding domain of P
protein was located at carboxyl-terminus regions (aa
345–412 and aa 479–568) (Ryan and Kingsbury, 1988;
Ryan and Portner, 1990), whereas the L protein binding
domain lies between the two nucleocapsid-binding do-
mains of P (aa 412–478) (Smallwood et al., 1994). The
mino-terminus of P protein contained two functionally
edundant regions, aa 1–77 and aa 78–145, both of which
re important for RNA synthesis (Curran et al., 1994).
oreover, aa 33–41 within 1–77 are essential for RNA
ncapsidation (Curran et al., 1995). The primary phos-
horylation site at S249 is not a part of these functional
omains. This indicated that phosphorylation at S249
ay not be important for virus replication. However,
hosphorylation at functional domains could be impor-
ant. We found that the major alternate phosphorylation
ites of TP2 (S447 and S449) are within L binding domain
nd phosphorylation sites S68 and S125 are located in
he amino-terminal domain that is important for RNA
ynthesis. Contrary to our expectation, the abrogation of
lternate phosphorylation sites in these regions in mu-
ant S249combo (in which all the alternate sites were
utated except the primary site, S249) failed to show any
ole for the alternate phosphorylation in minigenome
eplication. Taken together, our results suggest that both
lternate and primary phosphorylations of P are not
ssential for SV RNA synthesis.
For creation of the combo mutant, we changed eight
erine residues (at 68, 125, 192, 249, 257, 260, 447, and
49) to alanine. This in essence created a P mutant with
ess than 10% phosphorylation. It was believed that the
egative charge imparted by phosphorylation enhances
he transcription activity of P. However, our results
howed that abolishing the negative charge of the pro-
ein due to phosphorylation was of no consequence.
oreover, mutations in the functionally important regions
f P (at 68, 125, 447, and 449) did not inactivate P protein
see Fig. 5). These observations suggest that P can
ccommodate several changes in its sequence; some of
hese changes apparently cause conformational
hanges in the P protein but have no effect on the P
ctivity. Apparently, a high degree of flexibility in P is
eflected in a high degree of sequence variation in P
roteins of negative-sense RNA viruses.
The C proteins, which are expressed from an overlap-
ing reading frame from the P/C mRNA, have been sug-
ested to cause various effects on virus transcription,
eplication, and pathogenesis (Horikami et al., 1997; La-
orre et al., 1998; Nagai, 1999). Each of the mutations we
reated in P changed an amino acid in C, but the muta-
ion at S125 created a terminator codon in the C reading
rame, deleting 84 carboxyl-terminal aa of the C protein.
lthough we did not directly examine the expression of C
roteins, we expect expression of the full-length C pro-eins from all mutants except truncated C proteins from
he combo mutants. Both combo and S249combo mu-
ants of P supported the minigenome transcription and
eplication. Although the luciferase activity (Fig. 8A) is not
ignificantly different between the mutants and the WT,
orthern blotting show slightly enhanced replication
Fig. 8C) and transcription (Fig. 9). Previously, it was
hown that C proteins were downregulatory for mini-
enome transcription and replication (Cadd et al., 1996;
Tapparel et al., 1997). On the other hand, C proteins were
found essential for the full level of gene expression and
pathogenesis in mice when full-length virus clones were
used (Kurotani et al., 1998). Although our studies do not
address the function of C proteins, they do indicate that
the carboxyl-terminally truncated C proteins may have a
modulatory effect on the minigenome replication.
Paradoxically, phosphoproteins of negative-sense
RNA viruses are the least conserved, yet their propensity
for phosphorylation is stringently conserved. The SV P
protein is proposed to be a transcription factor; phos-
phorylation of P protein was believed to regulate the viral
polymerase activity by an increase of the overall negative
charge (Curran et al., 1994). Indeed, several studies with
VSV and RSV suggested that phosphorylation of P pro-
tein was essential for viral RNA transcription (Barik and
Banerjee, 1992a, 1992b; Beckes and Perrault, 1992; Das
et al., 1995; Gao and Lenard, 1995a, 1995b; Mazumder
and Barik, 1994; Pattnaik et al., 1997). Therefore, it is
rather surprising that our extensive analysis of SV P
protein phosphorylation failed to reveal any role of P
protein phosphorylation. In contrast to the previous stud-
ies that were performed in cell-free systems, our studies
were performed in cells.
However, there are some limitations in our studies.
The vaccinia virus/T7 RNA polymerase (VVTP) system
used for the minigenome replication studies could com-
plicate our results. From our past experience (Hu et al.,
1999), we believe that the VVTP system did not create
any problem in our studies. We did not find any signifi-
cant role of phosphorylation on minigenome replication
from the leader region, yet it is possible that phosphor-
ylation may be important for replication from the trailer
region. The less-than-10% phosphorylation of the P pro-
tein in combo may still be important to carry out the
required function of the P protein. At this level of phos-
phorylation, less than 10% of the P molecules will be
phosphorylated (Byrappa et al., 1996). The importance of
these phosphorylated molecules needs to be deter-
mined. Moreover, our phosphorylation studies focused
on the steady-state level of P phosphorylation, it is pos-
sible that temporal phosphorylation may be important for
P activity. Some of these issues will be clarified by
determining the function of alternate phosphorylation in
virus background.
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529ROLE OF SENDAI VIRUS PHOSPHOPROTEINMATERIALS AND METHODS
Recombinant plasmids and mutagenesis
WT SV L gene and NP gene recombinants, pGem-L
and pGem-NP, were described previously (Chandrika et
al., 1995; Curran et al., 1991). WT SV P/C gene plasmid
(pcDNAPC) and its primary phosphorylation mutant
(pcDNAPCS249A) were described previously (Byrappa et
al., 1996). The SV minigenome plasmid pSNDluc that
contains the luciferase (luc) gene flanked with the leader
and trailer noncoding regions of SV was described pre-
viously (Hu et al., 1999). To terminate T7 RNA polymerase
transcription efficiently, 1979-bp P gene HindIII–BamHI
fragment from pcDNAPC and pcDNAPCS249A were
cloned in vector pTF1(Takahashi et al., 1992). The P gene
in the resultant plasmids, pTF1SVP and pTF1SVPS249A,
was downstream of T7 promoter and upstream of T7
terminator. The pTF1SVPS249A (4977 bp) was used as
the PCR template for creation of all P gene deletion and
point mutants. Mutants were generated using the Vent
polymerase/PCR-based mutagenesis technique devel-
oped in our laboratory (Byrappa et al., 1995) with slight
modifications. This simple protocol yielded 100% effi-
ciency in generating mutants. Briefly, two primers (one
mutagenic and one complementary for point mutants or
both complementary for deletion mutants) were used to
amplify entire pTF1PCS249A using Vent DNA polymer-
ase (New England Biolabs, Beverly, MA). The blunt-
ended PCR product was purified and self-ligated. The
ligation product was digested with DpnI to remove any
contaminating methylated template DNA and was used
to transform the E. coli HB101 cells. Two transformant
colonies were picked and grown for mini-DNA prepara-
tion. Purified mini-prep DNA was used for sequencing to
check the mutation authenticity and for transfection.
The bicistronic minigenome, pSNDbiluc, was con-
structed by inserting a duplex of 24 nucleotides (59-
ATTAAGAAAAA CTT AGGGTGAAAG) consisting of the
end-intergenic-start (EIS) signals at nt 590 from the start
codon of luc gene in pSNDluc. To construct pSNDbiluc,
the entire pSNDluc was amplified by inverse PCR using
vent polymerase and a primer pair (Byrappa et al., 1995).
The primers were as follows: biluc1, 59-TTAGGGT-
GAAAG-ATTCCTCTGGATCTACTGGGTTACC-614 (posi-
tive-sense); and biluc2, 59-GTTTTTCTTAAT-TCATTAT-
CAGTGCAATTGTTTTGTC-565 (negative-sense). The 12-
mer underlined sequences denote two part of the EIS
region, and the 25-mer nonunderlined sequences come
from the luc gene. Numbers at the terminal nucleotide of
he primers denote the positions of the primers in luc.
igation of the amplified product yielded pSNDbiluc that
as sequence verified before use. Insertion of 24-bp EISragment in the minigenome maintained the “rule of six”
Calain and Roux, 1993) for the minigenome replication.Cell culture and DNA transfection
Transfections were performed in African green mon-
key kidney (CV-1) cells obtained from American Type
Culture Collection (Rockville, MD). Approximately 80–
90% confluent monolayer of CV-1 cells in a 35-mm dish
were infected with recombinant vaccinia virus vTF7-3 at
2–3 PFU/cell (Fuerst et al., 1986). One hour postinfection,
4 mg of mutant plasmid was transfected using Lipo-
ectAMINE in OptiMEM (Life Technologies, Grand Island,
Y) containing 20 mg/ml cytosine arabinoside (Ara-C).
For minigenome replication, 1 mg of pSNDluc, 100 ng of
NP, 50 ng of L, and different amount (40–160 ng) of P/C
(or P/C mutant) plasmids were cotransfected and incu-
bated at 33°C. For replication and subsequent transcrip-
tion of the bicistronic minigenome, 1 mg of pSNDbiluc
as substituted for pSNDluc.
etabolic labeling and immunoprecipitation
At 12–16 h after transfection of P mutants, transfection
edium was removed and cells were labeled metaboli-
ally. Two sets of dishes were used for labeling. In one
et, cells were transferred to methionine-free DMEM for
h and then labeled at 37°C for 8 h in the presence of
00 mCi/ml Trans35S-label (ICN) to measure the expres-
ion of P protein. In another set, cells were transferred to
hosphate-free DMEM for 1.5 h and then labeled with
arrier-free 32P-orthophosphate (0.6 mCi/ml) for 8 h at
37°C to assay P protein phosphorylation. Ara-C at 20
mg/ml was present in both 35S and 32P labeling medium
o inhibit the vaccinia virus replication. At the end of
abeling period, cells were washed with cold PBS (with
a21 and Mg21) and lysed in 0.5 ml of RIPA buffer (20 mM
Tris–HCl, pH 7.4, 2 mM EDTA, 0.15 M NaCl, 1% sodium
deoxycholate, 1% Triton X-100, 0.1% SDS) containing 1
mM PMSF and 1 mg/ml each of leupeptin and aprotinin.
or 32P-labeling, phosphatase inhibitors sodium or-
hovanadate (100 mm) and sodium fluoride (50 mM) were
lso added to RIPA buffer to prevent dephosphorylation
f P protein (Wang et al., 1995). Nuclei and debris were
emoved from cell lysate by centrifugation at 28,000 3 g
or 15 min. Then 50 ml of supernatants was used for
immunoprecipitation with 1 ml of rabbit antiserum (anti-P)
raised against P peptides corresponding to aa 274–298
and 453–477 (Byrappa et al., 1995) or 1 ml (1:10 diluted) of
anti-P monoclonal antibody, M56. The immunocomplex
was adsorbed onto 15 ml of Pansorbin (Calbiochem, San
Diego, CA). Pansorbin pellets were washed twice with
RIPA buffer plus 0.25% BSA and once with RIPA buffer
and suspended in 20 ml of 23 Laemmli’s loading buffer
(Laemmli, 1970). Samples were heated for 5 min at
100°C, and proteins were resolved in a 12.5% SDS–
polyacylamide minigel (Bio-Rad, Hercules, CA). Gels
were fixed, dried under vacuum, and exposed to Phos-
phorImager screen to quantify radioactivity in P protein
bands.
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530 HU AND GUPTATryptic phosphopeptide mapping
Tryptic phosphopeptides were analyzed by two-dimen-
sional separation on thin-layer cellulose plates (Boyle et
al., 1991). The protocol used in our study is identical to
the one used for SV P and HPIV1 P primary phosphory-
lation analysis (Byrappa and Gupta, 1999; Byrappa et al.,
1995, 1996). Briefly, 32P-labeled P proteins were immuno-
precipitated from 400 ml of cell lysate (as described
bove) and resolved in a 10% preparative SDS–polyac-
ylamide minigel. Proteins were transferred onto a nitro-
ellulose membrane (PROTRAN; Schleicher & Schuell,
eene, NH). The P protein band in the membrane was
liced out and cut into smaller pieces. The membrane
ieces were first washed with ddH2O and then soaked in
0.5% polyvinylpyrolidone (PVP 360; Sigma Chemical Co.,
St. Louis, MO) in 100 mM acetic acid at 37°C for 30 min
to block nonspecific absorption of trypsin. The mem-
brane was then extensively washed with ddH2O, fol-
owed by one wash with fresh 50 mM ammonium bicar-
onate. Digestion of P protein on membrane was carried
ut by 25 mg/ml trypsin (N-tosyl-L-phenylalanine chlo-
omethyl ketone-treated, sequencing grade; Sigma
hemical Co.) in 50 mM ammonium bicarbonate for
8–24 h. Digestion was monitored by the release of all
adioactivity from nitrocellulose membrane into solution.
he digest was lyophilized and dissolved in 5 ml of pH 1.9
uffer (formic acid/acetic acid/water 2.5:7.8:89.7) contain-
ng marker dyes: 5 mg/ml e-dinitrophenyl (DNP)-lysine
(yellow) and 1 mg/ml xylene cyanol FF (blue). Phos-
phopeptides were resolved on 100-mm-thick, 20 3 20-cm
icrocrystalline thin-layer cellulose plates (Kodak
3255). The first dimension electrophoresis was carried
ut at 500 V in pH 1.9 buffer until the yellow dye migrated
o 9 cm from the origin. After drying the plate completely,
econd dimension chromatography was performed in
hromatography buffer (n-butanol/pyridine/glacial acetic
cid/water 37.5:25:7.5:30) until the buffer front migrated 1
m from the top of the plate. Plates were dried, and
adioactivity in each phosphopeptide was measured by a
hosphorImager. Each plate was exposed to an X-ray
ilm for phosphopeptide map.
inigenome replication, luciferase assay, and
orthern blot analysis
Luciferase activity was used as a measure of mini-
enome replication. At 12–16 h after transfection of mini-
enome and three supporting plasmids, transfection me-
ium was replaced with HEPES-buffered DMEM (Sigma
hemical Co.) containing 20 mg/ml Ara-C and incubation
was continued at 33°C for an additional 24 h. At the end
of this period, the cells were harvested for luciferase
assay or for RNA preparation.
Luciferase activity was assayed according to a previ-
ously described method (Brasier, 1990). Briefly, cells
were washed with PBS (2Ca21), collected in 400 ml of100 mM potassium phosphate buffer (11 mM DTT, pH
7.8), and lysed by freeze/thaw. The clarified supernatant
was used for luciferase assay. Typically, 50 ml of super-
natant was mixed with 180 ml of luciferase assay buffer
(25 mM glycylglycine, 15 mM potassium phosphate, 15
mM MgSO4, 4 mM EGTA, 2 mM ATP, and 1 mM DTT, pH
7.8) and 100 ml of luciferin stock solution (1 mM D-
luciferin, 25 mM glycyglycine, pH 7.8, 10 mM DTT). Lu-
ciferase activity was measured immediately with a lumi-
nometer (Monlight 2010; Analytical Luminescence Labo-
ratory). Protein content of each supernatant was
determined using the Bio-Rad protein assay kit, and
relative light units per mg of protein were calculated.
Preparation of the total cellular RNA and encapsidated
RNA after micrococcal nuclease treatment has been
described in detail previously. Northern blot analysis of
replication products and synthesis of luciferase probes
have also been described (Hu et al., 1999).
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